205 related articles for article (PubMed ID: 23919478)
1. Liposomal formulations for inhalation.
Cipolla D; Gonda I; Chan HK
Ther Deliv; 2013 Aug; 4(8):1047-72. PubMed ID: 23919478
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in liposomal dry powder formulations: preparation and evaluation.
Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
[TBL] [Abstract][Full Text] [Related]
3. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
[TBL] [Abstract][Full Text] [Related]
4. New frontiers in aerosol delivery during mechanical ventilation.
Dhand R
Respir Care; 2004 Jun; 49(6):666-77. PubMed ID: 15165301
[TBL] [Abstract][Full Text] [Related]
5. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
Cipolla D; Wu H; Gonda I; Chan HK
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
[TBL] [Abstract][Full Text] [Related]
6. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
Martin AR; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
[TBL] [Abstract][Full Text] [Related]
7. Liposomes for Pulmonary Drug Delivery: The Role of Formulation and Inhalation Device Design.
Elhissi A
Curr Pharm Des; 2017; 23(3):362-372. PubMed ID: 27848886
[TBL] [Abstract][Full Text] [Related]
8. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
[TBL] [Abstract][Full Text] [Related]
9. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
[TBL] [Abstract][Full Text] [Related]
10. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers.
Gaspar MM; Gobbo O; Ehrhardt C
J Liposome Res; 2010 Mar; 20(1):55-61. PubMed ID: 19580376
[TBL] [Abstract][Full Text] [Related]
11. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
[TBL] [Abstract][Full Text] [Related]
12. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
[TBL] [Abstract][Full Text] [Related]
13. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.
Klyashchitsky BA; Owen AJ
J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295
[TBL] [Abstract][Full Text] [Related]
14. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
[TBL] [Abstract][Full Text] [Related]
15. Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size.
Li Z; Zhang Y; Wurtz W; Lee JK; Malinin VS; Durwas-Krishnan S; Meers P; Perkins WR
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):245-54. PubMed ID: 18759656
[TBL] [Abstract][Full Text] [Related]
16. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.
Beck-Broichsitter M; Rieger M; Reul R; Gessler T; Seeger W; Schmehl T
Eur J Pharm Biopharm; 2013 May; 84(1):106-14. PubMed ID: 23262166
[TBL] [Abstract][Full Text] [Related]
17. Formulations and nebulizer performance.
O'Riordan TG
Respir Care; 2002 Nov; 47(11):1305-12; discussion 1312-3. PubMed ID: 12425745
[TBL] [Abstract][Full Text] [Related]
18. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
20. Generation of aerosolized drugs.
Wolff RK; Niven RW
J Aerosol Med; 1994; 7(1):89-106. PubMed ID: 10147060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
